{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:07:00Z","timestamp":1773108420333,"version":"3.50.1"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0507900"],"award-info":[{"award-number":["2018YFA0507900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2022JQ-898"],"award-info":[{"award-number":["2022JQ-898"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273775"],"award-info":[{"award-number":["82273775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejmech.2023.115196","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T03:02:24Z","timestamp":1675911744000},"page":"115196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Recent advances on dual inhibitors targeting HIV reverse transcriptase associated polymerase and ribonuclease H"],"prefix":"10.1016","volume":"250","author":[{"given":"Jia-Xiong","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Kuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mou-Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Qi","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1161-5102","authenticated-orcid":false,"given":"Qin","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115196_bib1","first-page":"333","article-title":"HIV-1 reverse transcriptase\/integrase dual inhibitors: a review of recent advances and structure-activity relationship studies","volume":"20","author":"Rabbani","year":"2021","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.ejmech.2023.115196_bib3","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.bmc.2017.03.009","article-title":"Structural modifications of diarylpyrimidines (DAPYs) as HIV-1 NNRTIs: synthesis, anti-HIV activities and SAR","volume":"25","author":"Lu","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25844","article-title":"Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir\/emtricitabine\/tenofovir alafenamide","volume":"24","author":"Liou","year":"2021","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.ejmech.2023.115196_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/QAD.0000000000003085","article-title":"Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy","volume":"36","author":"Mills","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.ejmech.2023.115196_bib7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.apsb.2019.11.010","article-title":"Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years","volume":"10","author":"Zhuang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2023.115196_bib8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bmcl.2008.01.025","article-title":"Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase","volume":"18","author":"Wang","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115196_bib9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/molecules25051050","article-title":"Design of biphenyl-substituted diarylpyrimidines with a cyanomethyl linker as HIV-1 NNRTIs via a molecular hybridization strategy","volume":"25","author":"Lei","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115196_bib10","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1016\/j.bmc.2016.09.025","article-title":"Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase","volume":"24","author":"Gu","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib11","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1016\/j.bmc.2008.02.007","article-title":"Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine","volume":"16","author":"Wang","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib12","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1016\/j.bmc.2010.05.004","article-title":"Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase","volume":"18","author":"Wang","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib13","first-page":"238278","article-title":"The Need for development of new HIV-1 reverse transcriptase and integrase inhibitors in the aftermath of antiviral drug resistance","volume":"2012","author":"Wainberg","year":"2012","journal-title":"Sci. Tech. Rep."},{"key":"10.1016\/j.ejmech.2023.115196_bib14","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bmc.2014.01.054","article-title":"Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays","volume":"22","author":"Chen","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/biology1030521","article-title":"Inhibitors of HIV-1 reverse transcriptase associated ribonuclease H activity","volume":"1","author":"Ilina","year":"2012","journal-title":"Biology"},{"key":"10.1016\/j.ejmech.2023.115196_bib16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bmc.2014.11.032","article-title":"Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase","volume":"23","author":"Wu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib17","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2174\/0929867311320130011","article-title":"Rationally designed multitarget anti-HIV agents","volume":"20","author":"Zhan","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib18","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib19","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2174\/138161209788453266","article-title":"Designed multiple ligands: an emerging anti-HIV drug discovery paradigm","volume":"15","author":"Zhan","year":"2009","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2023.115196_bib20","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2174\/1381612820666140929095102","article-title":"Novel dual small-molecule HIV inhibitors: scaffolds and discovery strategies","volume":"21","author":"Song","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2023.115196_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.sbi.2019.11.011","article-title":"Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance","volume":"61","author":"Ruiz","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2023.115196_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jmb.2008.10.071","article-title":"Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition","volume":"385","author":"Sarafianos","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115196_bib23","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.3390\/ijms21249545","article-title":"Large multidomain protein NMR: HIV-1 reverse transcriptase precursor in solution","volume":"21","author":"Ilina","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115196_bib24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/v14051027","article-title":"Insights into HIV-1 reverse transcriptase (RT) inhibition and drug resistance from thirty years of structural studies","volume":"14","author":"Singh","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2023.115196_bib25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1021\/jm960056x","article-title":"Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors","volume":"39","author":"Hopkins","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3851\/IMP2690","article-title":"Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors","volume":"23","author":"Esposito","year":"2014","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ejmech.2023.115196_bib27","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1093\/nar\/gkg881","article-title":"Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors","volume":"31","author":"Klumpp","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib28","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/jm301271j","article-title":"Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening","volume":"56","author":"Bauman","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib29","doi-asserted-by":"crossref","first-page":"26566","DOI":"10.1074\/jbc.M116.753160","article-title":"HIV-1 reverse transcriptase polymerase and RNase H (ribonuclease H) active sites work simultaneously and independently","volume":"291","author":"Li","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib30","first-page":"3341","article-title":"Coordination between the polymerase and RNase H activity of HIV-1 reverse transcriptase","volume":"45","author":"Figiel","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib31","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/acs.jmedchem.6b00465","article-title":"Design, synthesis and biological evaluations of hydroxypyridone aarboxylic acids as inhibitors of HIV reverse transcriptase-associated RNase H","volume":"59","author":"Kankanalaa","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2018.12.061","article-title":"Identification of a novel DGK\u03b1 inhibitor for XLP-1 therapy by virtual screening","volume":"164","author":"Velnatia","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib33","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/v13081489","article-title":"Identification of novel HBV\/HDV entry inhibitors by pharmacophore- and QSAR-guided virtual screening","volume":"13","author":"Kirstgen","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2023.115196_bib34","doi-asserted-by":"crossref","first-page":"112479","DOI":"10.1016\/j.ejmech.2020.112479","article-title":"Discovery of novel aminopiperidinyl amide CXCR4 modulators through virtual screening and rational drug design","volume":"201","author":"Oum","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/07391102.2019.1700166","article-title":"Dual inhibitor design for HIV-1 reverse transcriptase and integrase enzymes: a molecular docking study","volume":"38","author":"Ercan","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115196_bib36","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1021\/bi9624696","article-title":"Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone","volume":"36","author":"Borkow","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2023.115196_bib37","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/cbdv.200490088","article-title":"9,10-Anthraquinones and other biologically active compounds from the genus Rubia","volume":"1","author":"Singh","year":"2004","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2023.115196_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0166-3542(91)90067-2","article-title":"Antiretroviral activities of anthraquinones and their inhibitory effects on reverse transcriptase","volume":"15","author":"Higuchi","year":"1991","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib39","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1073\/pnas.93.18.9742","article-title":"Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules","volume":"93","author":"Farnet","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2023.115196_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/157340609789117840","article-title":"Inhibition of HIV-1 ribonuclease H activity by novel frangula-emodine derivatives","volume":"5","author":"Tatyana","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib41","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1742-4658.2011.08057.x","article-title":"Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases","volume":"278","author":"Esposito","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2023.115196_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmech.2012.01.056","article-title":"Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach","volume":"50","author":"Distinto","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib43","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/cmdc.201402015","article-title":"Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase","volume":"9","author":"Meleddu","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115196_bib44","first-page":"193","article-title":"In-vitro testing of anti-HIV activity of some medicinal plants","volume":"1","author":"Rege","year":"2010","journal-title":"Indian J. Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00126839-200304020-00003","article-title":"Evaluation of the antiretroviral activity of a new polyherbal drug (Immu-25) in patients with HIV infection","volume":"4","author":"Usha","year":"2003","journal-title":"Drugs R"},{"key":"10.1016\/j.ejmech.2023.115196_bib46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejmech.2017.02.054","article-title":"Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase","volume":"130","author":"Sonar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib47","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1021\/jm401560v","article-title":"Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly","volume":"56","author":"Massari","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/cb8001039","article-title":"Vinylogous ureas as a novel class of inhibitors of reverse transcriptase-associated ribonuclease H activity","volume":"3","author":"Wendeler","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115196_bib49","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1021\/jm400405z","article-title":"Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H","volume":"56","author":"Masaoka","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib50","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/cmdc.201600015","article-title":"Studies on cycloheptathiophene-3-carboxamide derivatives as allosteric HIV-1 ribonuclease H inhibitors","volume":"11","author":"Corona","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115196_bib51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14756366.2018.1523901","article-title":"From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors","volume":"34","author":"Massari","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib52","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/cmdc.201600266","article-title":"Fragment-based discovery of 5-arylisatin-based inhibitors of matrix metalloproteinases 2 and 13","volume":"11","author":"Agamennone","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115196_bib53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570180812666150907203342","article-title":"Synthesis, neuro-protection and anti-cancer activities of simple isatin Mannich and Schiff bases","volume":"13","author":"Gang","year":"2016","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2023.115196_bib54","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1039\/C6MD00228E","article-title":"Design, synthesis, biological evaluation and docking studies of sulfonyl isatin derivatives monoamine oxidase and caspase-3 inhibitors","volume":"7","author":"Tavari","year":"2016","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2023.115196_bib55","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2174\/1568026615666150915112334","article-title":"A recent perspective on discovery and development of diverse therapeutic agents inspired from isatin alkaloids","volume":"16","author":"Rane","year":"2016","journal-title":"Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)"},{"key":"10.1016\/j.ejmech.2023.115196_bib56","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3109\/14756366.2016.1149479","article-title":"Inhibitory effects of isatin mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase","volume":"31","author":"Ozgun","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib57","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ejmech.2015.02.032","article-title":"(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazine-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase","volume":"93","author":"Meleddu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147225","article-title":"Ribonuclease H\/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6","volume":"11","author":"Corona","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115196_bib59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/14756366.2016.1238366","article-title":"Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase","volume":"32","author":"Meleddu","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib60","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/nar\/gki268","article-title":"Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones","volume":"33","author":"Budihas","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0009-2797(98)00078-7","article-title":"Mechanism of mitochondrial dysfunction and cytotoxicity induced by tropolones in isolated rat hepatocytes","volume":"116","author":"Nakagawa","year":"1998","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2023.115196_bib62","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/AAC.49.12.4884-4894.2005","article-title":"Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones","volume":"49","author":"Didierjean","year":"2005","journal-title":"J. Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115196_bib63","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1021\/jm2000757","article-title":"Synthesis, activity, and structural analysis of novel \u03b1-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H","volume":"54","author":"Chung","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202104112","article-title":"Synthesis of polyoxygenated tropolones and their antiviral activity against hepatitis B virus and herpes simplex virus-1","volume":"28","author":"Schiavone","year":"2022","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2023.115196_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104777","article-title":"Amide-containing \u03b1-hydroxytropolones as inhibitors of hepatitis B virus replication","volume":"177","author":"Li","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.antiviral.2017.06.014","article-title":"Efficacy and cytotoxicity in cell culture of novel \u03b1-hydroxytropolone inhibitors of hepatitis B virus ribonuclease H","volume":"144","author":"Lomonosova","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib67","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1128\/AAC.04617-14","article-title":"Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity","volume":"59","author":"Lu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115196_bib68","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1039\/C9MD00225A","article-title":"Importance of lipophilicity for potent anti-herpes simplex virus-1 activity of \u03b1-hydroxytropolones","volume":"10","author":"Berkowitz","year":"2019","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2023.115196_bib69","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1021\/acs.joc.6b00394","article-title":"Discovery and development of a three-component oxidopyrylium [5+2] cycloaddition","volume":"81","author":"D'Erasmo","year":"2016","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib70","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1039\/C6MD00238B","article-title":"Synthetic \u03b1-hydroxytropolones as inhibitors of HIV reverse transcriptase ribonuclease H activity","volume":"7","author":"Murelli","year":"2016","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2023.115196_bib71","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1039\/C7OB02453C","article-title":"Synthesis and biological assessment of 3,7-dihydroxytropolones","volume":"16","author":"Hirsch","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib72","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/acsomega.6b00123","article-title":"Free energy-based virtual screening and optimization of RNase H inhibitors of HIV-1 reverse transcriptase","volume":"1","author":"Zhang","year":"2016","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2023.115196_bib73","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/cbdd.13455","article-title":"Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV-1 RNase H inhibitors","volume":"93","author":"Gao","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2023.115196_bib74","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1248\/cpb.c21-00566","article-title":"Synthesis and evaluation of gallotannin derivatives as antioxidants and \u03b1-glucosidase inhibitors","volume":"69","author":"Machida","year":"2021","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejmech.2023.115196_bib75","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/antiox8060166","article-title":"Effects and mechanisms of tea and its bioactive compounds for the prevention and treatment of cardiovascular diseases: an updated review","volume":"8","author":"Cao","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2023.115196_bib76","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s11095-009-9932-0","article-title":"Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose","volume":"26","author":"Zhang","year":"2009","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejmech.2023.115196_bib77","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.drudis.2012.02.015","article-title":"Catechins containing a galloyl moiety as potential anti-HIV-1 compound","volume":"17","author":"Zhao","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.115196_bib78","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hep.24803","article-title":"(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry","volume":"55","author":"Calland","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2023.115196_bib79","first-page":"84","article-title":"3-Hydroxypyrimidine-2,4-dione derivatives as HIV reverse transcriptase-associated RNase H inhibitors: QSAR analysis and molecular docking studies","volume":"19","author":"Mostoufa","year":"2020","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.ejmech.2023.115196_bib80","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ejmech.2018.07.035","article-title":"6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H","volume":"156","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib81","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1021\/acs.jmedchem.7b00440","article-title":"Double-winged 3-hydroxypyrimidine-2,4-diones: potent and selective inhibition against HIV-1 RNase H with significant antiviral activity","volume":"60","author":"Vernekara","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib82","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1021\/jm1014378","article-title":"3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase","volume":"54","author":"Tang","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib83","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.bmcl.2011.02.069","article-title":"6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase","volume":"21","author":"Tang","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115196_bib84","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1021\/jm070512p","article-title":"Rationally designed dual inhibitors of HIV reverse transcriptase and integrase","volume":"50","author":"Wang","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/ml1002162","article-title":"N-3 hydroxylation of pyrimidine-2,4-diones yields dual inhibitors of HIV reverse transcriptase and integrase","volume":"2","author":"Tang","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115196_bib86","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1021\/acs.jmedchem.6b00040","article-title":"3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides potently inhibit HIV-1 integrase and RNase H","volume":"59","author":"Wu","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib87","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3390\/molecules24091718","article-title":"Pyrimidine 2,4-diones in the design of new HIV RT inhibitors","volume":"24","author":"Romeo","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115196_bib88","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejmech.2017.01.041","article-title":"6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: impacts of the 3-OH on inhibiting RNase H and polymerase","volume":"128","author":"Tang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib89","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1021\/acs.jmedchem.5b01879","article-title":"3-Hydroxypyrimidine-2,4-diones as selective active site inhibitors of HIV reverse transcriptase-associated RNase H: design, synthesis, and biochemical evaluations","volume":"59","author":"Tang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib90","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejmech.2018.07.039","article-title":"6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity","volume":"156","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib91","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejmech.2019.01.081","article-title":"Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: tolerance of a nonflexible linker","volume":"166","author":"Tang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib92","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00245-17","article-title":"3-Hydroxypyrimidine-2,4-diones as novel hepatitis B virus antivirals targeting the viral ribonuclease H","volume":"61","author":"Huber","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115196_bib93","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1093\/nar\/gkg881","article-title":"Two-metal-ion mechanism of RNA cleavage by HIV RNase H andmechanism based design of selective HIV RNase H inhibitors","volume":"31","author":"Klumpp","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib94","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1021\/jm1014692","article-title":"Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and\/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function","volume":"54","author":"Billamboz","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib95","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1021\/cb4000426","article-title":"2-Hydroxyisoquinoline-1,3-(2H,4H)-diones (HIDs), novel inhibitors of HIV integrase with a high barrier to resistance","volume":"8","author":"Desimmie","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115196_bib96","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1021\/ml400009t","article-title":"4-Substituted 2-hydroxyisoquinoline-1,3(2H, 4H)-diones as a novel class of HIV-1 integrase inhibitors","volume":"4","author":"Billamboz","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115196_bib97","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1021\/jm500109z","article-title":"Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors","volume":"57","author":"Suchaud","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib98","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1021\/jm8007085","article-title":"Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain","volume":"51","author":"Billamboz","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib99","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejmech.2010.11.033","article-title":"2-Hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4","volume":"46","author":"Billamboz","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/jm501132s","article-title":"Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities","volume":"58","author":"Vernekar","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib101","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01351-17","article-title":"A 2-Hydroxyisoquinoline-1,3-dione active-site RNase H inhibitor binds in multiple modes to HIV-1 reverse transcriptase","volume":"61","author":"Kirby","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115196_bib102","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejmech.2017.03.059","article-title":"Synthesis, biological evaluation and molecular modeling of 2-hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase","volume":"133","author":"Tang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib103","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2014.05.007","article-title":"Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity","volume":"108","author":"Cai","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib104","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bmc.2011.10.058","article-title":"The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus","volume":"20","author":"Chen","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib105","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1016\/j.bmcl.2010.08.135","article-title":"Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold","volume":"20","author":"Williams","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115196_bib106","series-title":"The Development of Novel Pyridopyrimidinone Antiretrovirals with Selective Activity against HIV Ribonuclease H. Cold Spring Harbor Laboratories Conference on Retroviruses, Cold Spring Harbor, NY, May 21-26, 2012","author":"Gerondelis","year":"2012"},{"key":"10.1016\/j.ejmech.2023.115196_bib107","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/ph14090893","article-title":"Pyrroles as privileged scaffolds in the search for new potential HIV inhibitors","volume":"14","author":"Bianco","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115196_bib108","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1128\/AAC.01455-09","article-title":"Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug resistant human immunodefciency virus type 1","volume":"54","author":"Corbau","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115196_bib109","doi-asserted-by":"crossref","first-page":"ftx078","DOI":"10.1093\/femspd\/ftx078","article-title":"Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions","volume":"75","author":"Corona","year":"2017","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.ejmech.2023.115196_bib110","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4155\/fmc.13.178","article-title":"Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase","volume":"5","author":"Corona","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib111","series-title":"Sulfur-containing Drugs and Related Organic Compounds, Chemistry, Biochemistry and Toxicology: Metabolism and Pharmacokinetics of Sulfur-Containing Drugs","author":"Damani","year":"1989"},{"key":"10.1016\/j.ejmech.2023.115196_bib112","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF03189993","article-title":"Drug-induced immunotoxicity","volume":"23","author":"Dansette","year":"1998","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2023.115196_bib113","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1080\/14756366.2020.1835884","article-title":"Scaffold hopping and optimisation of 3\u2019,4\u2019-dihydroxyphenyl-containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H","volume":"35","author":"Toccoa","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib114","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00044-011-9705-2","article-title":"Synthesis, antimycobacterial, antiviral, antimicrobial activities, and QSAR studies of isonicotinic acid-1-(substituted phenyl)-ethylidene\/cyclohept-ylidene hydrazides","volume":"21","author":"Judge","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib115","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00044-011-9664-7","article-title":"Synthesis, antimycobacterial, antiviral, antimicrobial activities, and QSAR studies of nicotinic acid benzylidene hydrazide derivatives","volume":"21","author":"Narang","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061338","article-title":"2-(Arylamino)-6-(trifluoromethyl)nicotinic acid derivatives: new HIV-1 RT dual inhibitors active on viral replication","volume":"25","author":"Corona","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115196_bib117","doi-asserted-by":"crossref","first-page":"112944","DOI":"10.1016\/j.ejmech.2020.112944","article-title":"Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase","volume":"209","author":"Massari","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib118","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/molecules25051183","article-title":"1,2,4-Triazolo[1,5-a]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-associated ribonuclease H activity","volume":"25","author":"Desantis","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115196_bib119","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bmcl.2004.01.037","article-title":"6-Aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays","volume":"14","author":"Costi","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115196_bib120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2004.11.002","article-title":"6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro","volume":"65","author":"Tramontano","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib121","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1021\/jm401040b","article-title":"(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach","volume":"56","author":"Costi","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib122","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1021\/jm501799k","article-title":"Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain","volume":"58","author":"Crucitti","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib123","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1128\/AAC.03605-14","article-title":"Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by diketo acid derivatives","volume":"58","author":"Corona","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115196_bib124","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.antiviral.2016.09.008","article-title":"New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H","volume":"134","author":"Corona","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115196_bib125","doi-asserted-by":"crossref","first-page":"23873","DOI":"10.1039\/C8CP01843J","article-title":"Prediction of the binding mode and resistance profile for a dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase-associated ribonuclease H","volume":"20","author":"Yang","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejmech.2023.115196_bib126","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/acsmedchemlett.9b00617","article-title":"Pyrrolyl pyrazoles as non-diketo acid inhibitors of the HIV-1 ribonuclease H function of reverse transcriptase","volume":"11","author":"Messore","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115196_bib127","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1021\/jm8001422","article-title":"Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities","volume":"51","author":"Santo","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib128","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1021\/jm0511583","article-title":"Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action","volume":"49","author":"Santo","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib129","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1021\/jm5001503","article-title":"Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase","volume":"57","author":"Costi","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib130","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1021\/acs.jmedchem.5b00159","article-title":"N-substituted quinolinonyl diketo acid derivatives as HIV integrase strand transfer inhibitors and their activity against RNase H function of reverse transcriptase","volume":"58","author":"Pescatori","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib131","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1021\/acs.jmedchem.1c00535","article-title":"Quinolinonyl non-diketo acid derivatives as inhibitors of HIV-1 ribonuclease H and polymerase functions of reverse transcriptase","volume":"64","author":"Messore","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115196_bib132","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/cb600303y","article-title":"HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site","volume":"1","author":"Himmel","year":"2006","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115196_bib133","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.3390\/molecules26133821","article-title":"Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions","volume":"26","author":"Meleddu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115196_bib134","series-title":"Substituted 3-Hydroxy-4-Pyridone Derivative","author":"Fujishita","year":"2010"},{"key":"10.1016\/j.ejmech.2023.115196_bib135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40265-019-01247-1","article-title":"Dolutegravir\/Lamivudine single-tablet regimen: a review in HIV-1 infection","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423001113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423001113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:49:41Z","timestamp":1759330181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423001113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":133,"alternative-id":["S0223523423001113"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115196","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances on dual inhibitors targeting HIV reverse transcriptase associated polymerase and ribonuclease H","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115196"}}